Increased Risk of Heart Failure Hospitalization With GLP-1 Receptor Agonists in Patients With Reduced Ejection Fraction: A Meta-Analysis of the EXSCEL and FIGHT Trials-Reference-Cited by-同舟云学术

Increased Risk of Heart Failure Hospitalization With GLP-1 Receptor Agonists in Patients With Reduced Ejection Fraction: A Meta-Analysis of the EXSCEL and FIGHT Trials

Published:2023-07 Issue:7 Volume:29 Page:1107-1109
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

Neves JOÃO SÉRGIO^ORCID,PACKER MILTON,FERREIRA JOÃO PEDRO

Funder

Fundação para a Ciência e a Tecnologia

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference5 articles.

1. Glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes with and without chronic heart failure: a meta-analysis of randomized placebo-controlled outcome trials;Ferreira;Diabetes Obes Metab,2023

2. Effect of Liraglutide on Left Ventricular Function in Stable Chronic Heart Failure Patients With and Without Diabetes;Margulies;JAMA,2016

3. Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE): a multicentre, double-blind, randomised, placebo-controlled trial;Jorsal;Eur J Heart Fail,2017

4. Glucagon-like peptide 1 receptor agonists in heart failure: the need for a rewind;Ferreira;Eur J Heart Fail,2022

5. Effect of once-weekly exenatide in patients with type 2 diabetes mellitus with and without heart failure and heart failure-related outcomes: insights from the EXSCEL trial;Fudim;Circulation,2019

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Glucagon-like Peptide-1 Receptor Agonists on Cardiac Function, Exercise Capacity and Quality of Life;Cardiac Failure Review;2024-09-11

2. GLP-1 receptor agonists in heart failure: how far to expand use?;The Lancet;2024-09

3. Should the SELECT Trial Make Us Comfortable Using GLP-1 Receptor Agonists in HFrEF?;Journal of the American College of Cardiology;2024-09

4. Obesity and Weight Loss Strategies for Patients With Heart Failure;JACC: Heart Failure;2024-09

5. Reply to ‘Empagliflozin and glucagon‐like peptide‐1 receptor agonists: The brothers for heart failure?’;European Journal of Heart Failure;2024-08-15